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Microglia are the endogenous immune cells of the brain and act as sensor of infection
and pathologic injury to the brain, leading to a rapid plastic process of activation that
culminates in the endocytosis and phagocytosis of damaged tissue. Microglia cells
are the most plastic cells in the brain. Microglia isolation from their environment as
well as culturing them in the presence of serum alter their function and lead to a
rapid loss of their signature gene expression. Previous studies have identified pivotal
factors allowing microglia culture in the absence of serum. Here, we have further
characterized the function, expression of markers, metabolic status and response to pro
and anti-inflammatory stimulus of microglia isolated by magnetic-activated cell sorting
and cultured in a chemically defined medium. We have compared this new method
with previous traditional protocols of culturing microglia that use high concentrations
of serum.
Keywords: microglia, culture, ramification, phagocytosis, metabolic reprogramming, purinergic receptors,
motility
INTRODUCTION
Microglial cells are the resident macrophages of the central nervous system (CNS). They arise from
early myeloid progenitors in the embryonic yolk sac that migrate and colonize CNS (Ginhoux
et al., 2010; Kierdorf et al., 2013). These progenitors expand, proliferate and differentiate into
parenchymal microglia and their lineage is preserved through continuous self-renewal even in
pathological conditions (Ajami et al., 2011). The other CNS non-parenchymal macrophages,
including perivascular, meningeal and choroid plexus macrophages, share with parenchymal
microglia the prenatal origin, the lack of replacement by circulating blood cells, and major parts
of the transcriptional profile (Goldmann et al., 2016).
Microglia are characterized by a continuous surveillance of their environment, in order to
maintain tissue integrity and homeostasis (Davalos et al., 2005; Nimmerjahn et al., 2005). Moreover,
they play a pivotal role in a wide and heterogeneous range of physiological responses, actively
interacting with almost all CNS cell types. These functions vary during the different stages of
development, and they transcend the expected immunity-specific activities such as phagocytosis
of myelin debris or apoptotic cells. Microglia is involved during development in circuit refinement
through synaptic pruning (Schafer et al., 2012) and in myelogenesis (Wlodarczyk et al., 2017). In
the adult, microglia is involved in maintaining the homeostasis of the baseline neurogenic cascade
through the elimination of neural precursor cells (NPCs; Sierra et al., 2010).
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Microglial cells are widely studied in pathological
conditions as well, as its activation is thought to contribute
to neuroinflammation, a crucial hallmark of neurodegenerative
disorders such as Alzheimer’s disease, Parkinson’s disease
or multiple sclerosis (MS). These diverse and sometimes
contradictory functions in which microglia/macrophages are
involved can be explained on the basis of a broad spectrum
of activation states, depending on the nature of the activating
stimulus (Xue et al., 2014). These different activation states
are associated to a metabolic reprogramming. Similar to
macrophages (Kelly and O’Neill, 2015; Stienstra et al., 2017),
microglia exposed to pro-inflammatory stimulus shift their
metabolism from oxidative phosphorylation (OXPHOS) to
aerobic glycolysis (Hu et al., 2019; Nair et al., 2019), in an
event similar to the Warburg effect suffered by cancer cells
(Andrejeva and Rathmell, 2017). This metabolic reprogramming
is essential to activate cellular defense mechanisms and
to manage various microenvironments in inflamed tissue
(Kelly and O’Neill, 2015; Van den Bossche et al., 2017;
Holland et al., 2018). In contrast, macrophages exposed to
anti-inflammatory stimulus are primarily characterized by
oxidative phosphorylation and increased fatty acid oxidation
for ATP synthesis (Stienstra et al., 2017; Van den Bossche
et al., 2017), a fact that it has not been corroborated in
microglia cells.
The endeavor to understand microglial functions and
specifications has led to the development of both in vivo and
in vitro models. The former include microglial deficient mice,
whereas the latter comprise immortalized cell lines like BV-2
or primary microglial cultures. Among the primary cultures,
microglia isolated from mixed glial cell cultures are among the
most common ones. Nevertheless, almost all in vitro models
present a drawback: they are performed in the presence of
serum to support cell survival. Microglia in these cultures
are highly proliferative and display an amoeboid morphology,
typical of the injured brain, and differ from highly ramified
surveillant microglia. In order to take over that limitation,
Bohlen et al. (2017) developed a serum-free medium in which
primary microglia could survive at higher rates and develop
a ramified morphology that resembles that acquired by these
cells in the normal adult brain (Bohlen et al., 2017). To
achieve so, they identified three factors, TGF-β2, IL-34, and
cholesterol (TIC factors), essential to their survival. Here, we
have gone a step forward to characterize morphologically and
functionally these primary cells isolated by Magnetic-activated
cell sorting (MACS) from postnatal rat brain and cultured in
the presence of a defined medium containing TIC factors, and
to determine whether these cells can recapitulate the microglial
metabolic reprogramming described before in response to
stimulation with pro-inflammatory factors. In comparison to
microglia derived from mixed glial cell culture with serum-
supplemented medium, microglia growth in the chemically
defined medium showed a downregulation of almost all the
activation markers analyzed. Moreover, microglial phagocytic
activity is lowered even though their motility is enhanced.
Importantly, we observed that these cells can be activated and
reprogram their metabolism.
METHODS
Animals
All experiments were performed according to the procedures
approved by the Ethics Committee of the University of
the Basque Country (UPV/EHU). Animals were handled in
accordance with the European Communities Council Directive.
All possible efforts were made to minimize animal suffering and
the number of animals used.
Serum-Exposed Microglia Isolation and
Culture
Primary mixed glial cultures were prepared from the cerebral
cortex of neonatal rats (P0-P2). After 10–15 days in culture,
microglia were isolated by mechanical shaking (400 rpm, 1 h)
and purified by plating on non-coated bacterial grade Petri dishes
(Sterilin; Thermo Fisher) as previously described (Domercq
et al., 2007). Microglial cells obtained with this procedure
were cultured in Dulbecco’s Modified Eagle Medium (DMEM;
Gibco) supplemented with 10% Fetal Bovine Serum (FBS; Gibco).
We have selected this protocol for culturing microglia, the
most common one, despite the existence of other methods
using lower concentration of serum and mild trypsinization
(Saura et al., 2003).
Microglial cells were stimulated with pro-inflammatory or
anti-inflammatory factors as previously described with minor
modifications (Zabala et al., 2018). Briefly, cells were treated
during 24 h with pro-inflammatory factors LPS (10 ng/ml)
plus IFN-γ (20 ng/ml) or with the anti-inflammatory cytokines
interleukins IL-13 (50 ng/ml) and IL-4 (20 ng/ml).
MACS Isolated Microglia Culture
Microglial cells were isolated by MACS from P10-P12 rats,
following a protocol similar to that stablished in the Neural
Tissue Dissociation Kit P datasheet (Miltenyi Biotec). Briefly,
the whole brain (without cerebellum) was carefully dissected
and meninges were removed. Subsequently, the brain tissue
was dissociated both enzymatically and mechanically using
the indicated enzymatic mixes and a dounce homogenizer,
respectively. Myelin was removed in order to increase the
yield using a Percoll gradient protocol, and finally CD11b+
cells were sorted by MACS using species-specific microbeads
(Miltenyi Biotec). Approximately 2–3 million cells were obtained
from a single brain.
These cells were subsequently resuspended and cultured in
a chemically defined medium containing TGF-β2, cholesterol
and macrophage colony-stimulating factor (M-CSF; 100 ng/ml,
Peprotech) (TIC factors), as previously described with minor
modifications (Bohlen et al., 2017). In our case, IL-34 was
replaced with M-CSF that acts via the same signaling pathway
(CSF1R). Microglial cells were cultured with a variable density
depending on the experiment; normally, in order to increase
the outcome of functional cells, the density of the culture was
high (30,000–60,000 cells per well). Medium was refreshed every
day until the cells were used/analyzed. Cell purity was analyzed
using antibody markers for astrocytes (GFAP; 1:100, Millipore),
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neurons (NeuN; 1:500, Millipore) and oligodendrocytes (Olig2;
1:200, Millipore).
Cells obtained through the MACS protocol were stimulated
with proinflammatroy factors LPS (10 ng/ml) plus IFN-γ
(20 ng/ml) or with the anti-inflammatory cytokines interleukins
IL-13 and IL-4 at low concentration (low; IL-13, 50 ng/ml and IL-
4, 20 ng/ml) or high concentration (high; IL-13, 100 ng/ml and
IL-4, 50 ng/ml).
Immunofluorescence Analysis
In order to characterize MACS-isolated primary microglia,
several immunocytochemistry (ICC) assays were performed
on them as well as on traditional microglia cultures in the
presence of serum. Specific ICC were performed in order to
assay the expression of activation markers, purinergic receptors,
transcription factors and markers of autophagy lysosomes and
lipid bodies. Cells were fixed in 4% p-formaldehyde (PFA) in
PBS and processed for ICC as previously described (Domercq
et al., 1999). Primary antibodies were used as follows to: iNOS
(1:500, BD Bioscience), MRC1 (1:1000, Abcam), CD68 (1:100,
Bio-Rad), Iba1 (1:500, Wako), IRF5 (1:100, Millipore), P2 × 7R
(1:100, Alomone), P2 × 4R (1:400, Alomone), P2Y12 (1:200,
Anaspec) and LC3B (1:2000, Novus Biologicals). Lipid bodies
(LBs) were stained using BODIPY 493/503 (Invitrogen). As
secondary antibodies, we used goat anti-rabbit Alexa Fluor 488
(1:250, Invitrogen), goat anti-rabbit Alexa Fluor 594 (1:250,
Invitrogen), goat anti-mouse Alexa Fluor 594 (1:250, Invitrogen)
and goat anti-rat Alexa Fluor 488 (1:250, Invitrogen). Images
were acquired using a laser scanning confocal Olympus Fluoview
FW500 microscopy or a Leica TCS STED CW SP8 super-
resolution microscope, using the same settings for all samples
within one experimental group.
All the image analysis was performed with the ImageJ software
(NIH). Morphology analysis of microglia was performed with
ImageJ software as described before (Fontainhas et al., 2011).
The area of the cell was determined on the basis of Iba1
immunostaining using NIH ImageJ. The number of processes
arising from soma was quantified manually. Both parameters
were analyzed in 30–50 cells in three independent experiments.
Mean fluorescence intensity (fluorescence intensity/cell area,
as defined in ImageJ) of purinergic receptors, IRF5, iNOS,
MNR, and Bodipy labeling was calculated in individual cells,
defined on the basis of Iba1 immunostaining (data was obtained
from 20–30 cells per coverslip from 3–5 different experiments
performed in duplicate). Regarding IRF5, the mean intensity
(IRF5 fluorescence/ROI area) was calculated in defined ROIs in
cytoplasm and nucleus and the results were expressed as the
ratio (mean fluorescence cytoplasm/mean fluorescence nucleus).
CD68+ and LC3+ puncta per cell were quantified at individual
cells in 20–30 cells from three independent cultures.
Phagocytosis Assays
To evaluate phagocytosis, microglia were incubated with
fluorescent microbeads (FluoSpheresTM carboxylate-modified
microspheres, 2 µm, red fluorescent (580/605); Invitrogen)
for 1 h at 37◦C, rinsed, and fixed with 4% PFA. Cells were
stained using antibodies to Iba1 (1:500; Wako) and Hoechst
33258. Fluorescent microbeads were quantified using ImageJ
on microglial cells outlined with the Iba1 immunostaining
as the defining parameter for the ROIs. An intracellular
section of the cell was selected on the basis of Iba1 staining
to assure intracellular location of the microbeads. Identical
acquisition parameters were used for image capture of individual
experiments. Results were expressed as the percentage of beads
phagocytosed versus total beads (10 fields/experiment, n = 3
independent experiments) and the percentage of phagocytic cells
(≥1 bead, at least 50 cells were analyzed in each experiment, n = 3
independent experiments).
Furthermore, phagocytic capacities were also assessed by
measuring the internalization and degradation of myelin. With
that in mind, myelin was isolated from adult rat spinal cord with
sucrose gradient centrifugations (Norton and Poduslo, 1973), and
labeled with Alexa 488-NHS dye (A2000 Life Technologies) for
1 h at RT in PBS. Subsequent dialysis helped removing dye excess,
and the resulting dyed myelin was stored until its addition to
the microglia cultures in a final concentration of 5 µg/mL (1:200
dilution). To evaluate myelin endocytosis, the cells were rinsed
and fixed after 1 h of incubation at 37◦C. On the other hand,
in order to evaluate myelin degradation by the lysosomes, the
excess of myelin was removed and cells were subsequently chased
after 24 h. Microglia were then stained using antibodies to Iba1
and Hoechst 33258, and myelin was quantified at both conditions
on Iba1+ cells using ImageJ (data was obtained from at least 50
cells/experiment from three independent experiments).
Metabolism Analysis
Real time measurements of OCR and ECAR were performed
using a Seahorse XFe96 Extracellular Flux Analyzer (Agilent).
Microglia cells were seeded as a monolayer in a 96-well
microplate and the analysis was performed following the
manufacturer instructions. Before the assay, cells were washed
and equilibrated in the XF Assay modified DMEM medium
for 30 min at 37◦C. The real levels of oxygen consumption
rate were determined in response to the sequential addition of
oligomycin (2 mM), FCCP (1 mM) and rotenone/antimycin
A (0.5 mM). Basal mitochondrial respiration was calculated
as the last measurement before addition of oligomycin –
non-mitochondrial respiration (minimum rate measurement
after Rot/AntA). Spare capacity was calculated by subtracting
basal respiration from the maximum rate measurement after
addition of FCCP. Estimated ATP production designated the last
measurement before addition of oligomycin – the minimum rate
after oligomycin. All these parameters were obtained using the
Agilent Report Generator.
Microglial Dynamics Analysis
For these purposes, cells were cultured in 35 mm Glass
Bottom Dishes (MatTek Corporation). Following 2 or 3 days
of incubation at 37◦C, the dishes were transferred to the
Nikon Biostation IM-Q microscope, and live images of cells
were captured with the time lapse imaging system to study
microglial dynamics. The settings for the recording were as
follows: 3 h with an acquisition of a frame per minute. The
tracking of the different cells acquired in those time-lapses were
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obtained using the Kinovea software (n = 20 cells from three
independent experiments). The accumulated distance traveled by
the individual cells was quantified by measuring the euclidean
distances covered at every frame; subsequently, the mean speed
of the cells was calculated dividing these distances by the time.
RESULTS
Microglial Morphology and Phenotype
Changes in a Chemically Defined
Medium
Using CD11b-microbeads for the isolation protocol, microglia
cells were isolated with a high purity from postnatal rat brains.
The vast majority of these cells (purity > 99%) were positive
for the phagocyte marker Iba1, whereas practically no labeling
of astrocytes (<1%), oligodendrocytes or neurons was observed
in our cultures.
Morphological analysis based on Iba1 immunostaining
showed a significant increase in the number of processes
and a decrease in the cell body area in microglia cultured
in defined medium (Figure 1). Thus, microglia acquired a
highly ramified morphology, with multiple processes branching
off the soma, resembling the typical microglia morphology
presented in physiological conditions in the brain. In contrast,
those cells cultured with serum presented an amoeboid-like
phenotype (Figure 1).
Since purinergic receptors, particularly P2Y12, P2 × 4 and
P2 × 7, are pivotal in microglial activation and function
(Clark et al., 2010; Beaino et al., 2017; Zabala et al., 2018), we
checked whether the presence of serum influences purinergic
receptor immunoreactivity. Microglia activation is associated
to specific gene signatures, such as P2Y12 downregulation
and P2 × 4 overexpression (Domercq et al., 2010). No
change was detected in P2 × 7R expression between both
culture conditions (Figure 2B). In contrast, we detected a
significant increase in P2Y12R immunoreactivity and a drastic
downregulation of P2 × 4R immunoreactivity in microglia
cultured in defined medium (Figures 2A,C). Since P2 × 4R
expression is controlled by the transcription factor interferon
regulatory factor-5 (IRF5) (Masuda et al., 2014), a key regulator of
the inflammatory reaction, we analyzed IRF5 immunoreactivity
in both populations. Total IRF5 immunoreactivity was reduced
in microglia cultured in defined medium. Moreover, microglia
cultured in defined medium showed a reduction in nuclear IRF5
immunoreactivity, as analyzed by the nucleus/cytoplasm labeling
ratio (Figure 2D), suggesting a decreased level of IRF5-targeted
genes transcription.
Phagocytosis and Surveillance
In light of the previously mentioned results, we explored whether
primary microglia basic functionalities were altered as well in
the absence of serum. Firstly, phagocytosis was assessed treating
the cells with specific fluorescent microbeads for an hour pre-
fixation. We observed a significant decrease in the percentage
of microbeads phagocytosed per cell as well in the number
of phagocytic cells in microglia cultured in defined medium
(Figure 3A). However, and in contrast to results obtained
previously (Bohlen et al., 2017), microglia cultured in defined
medium were still able to phagocyte microbeads (not opsonized)
although less efficiently. To further explore phagocytosis, we
isolated myelin from adult rat whole brain using sucrose gradient
(Norton and Poduslo, 1973), labeled with Alexa 488 and added
to microglial cells. We quantified myelin internalization and
delivery to lysosomes for degradation. As with microbeads, we
observed a significant reduction on myelin endocytosis at 1 h
in microglia cultured in defined medium (Figure 3B). Moreover,
myelin in microglia cultured in defined medium was not reduced
at 24 h (Figure 3B), indicating a failure or a less efficient
degradation capacity of these microglia.
In relation with phagocytosis, we also tested markers of
autophagy and lysosomes. CD68 is a protein found on lysosomal
membrane that is associated to the cell’s phagocytic activity.
We found CD68 immunoreactivity to be severely reduced
in microglia cultured in defined medium (Figure 4A). We
further analyzed microtubule-associated protein 1A/1B–light
chain 3 (LC3) immunoreactivity. In myeloid cells, LC3-associated
phagocytosis (LAP), a non-canonical type of autophagy, couples
the processing of engulfed particles, including pathogens,
immune complexes, and dying cells, to regulation of macrophage
immune responses (Cunha et al., 2018). LC3 immunostaining
was also reduced in microglia cultured in defined medium
(Figure 4B). Altogether, data indicated that microglia cultured in
the defined medium have reduced phagocytosis.
Microglia exposed to pro-inflammatory stimuli such as
LPS increases phagocytosis (Rangaraju et al., 2018) although
surveillant microglia constantly move their processes to patrol
the environment and phagocytose apoptotic cells and synapses
during development (Sierra et al., 2010; Paolicelli et al., 2011).
In order to check whether stimulation with pro-inflammatory
factors increases phagocytosis in defined medium microglia, we
treated cells with LPS at a concentration that does not affect
significantly cell survival (100 ng/ml; 24 h) and immediately
tested microglia phagocytosis. We observed a significant increase
in the percentage of phagocytic cells when exposed to fluorescent
microbeads (Figure 4C).
In the normal physiological condition, microglia scan
constantly brain parenchyma by constant process movement.
Live imaging of the microglia cells demonstrated that microglia
cultured in defined medium have higher motility. The mean
speed of the cells was enhanced and cells moved longer distances
(Figure 5 and Supplementary Videos). These data support the
idea that the phenotype of microglia cultured with defined
medium actually resembles more the one present in the brain in
physiological conditions.
Polarization and Metabolic
Reprogramming
Microglia display an enormous plasticity in their responses
to injury, ranging from responses that contribute to damage
to responses essential for regeneration and inflammation
resolution (Fumagalli et al., 2018). Much of this work has been
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FIGURE 1 | Representative images of Iba1+ microglia cultured in the presence of serum or in a chemically defined medium. Scale bar = 25 µm. Histograms
represent the morphological characterization of microglia in defined medium and serum-exposed microglia. Data shows mean ±s.e.m. of 20–30 cells from three
different experiments. ***p < 0.001, Student’s t-test.
performed in vitro using protocols to activate cells toward a
pro-inflammatory phenotype and toward an anti-inflammatory
and regenerative phenotype. Microglia cells were primed pro-
inflammatory and anti-inflammatory factors (see details in
section “Methods”) and analyzed by immunocytochemistry using
pro-inflammatory (iNOS) and anti-inflammatory (mannose
receptor; MRC1) markers. Stimulation with pro-inflammatory
factors, LPS (10 ng/ml)+ IFNγ (20 ng/ml), induced a significant
increase in iNOS immunoreactivity in both culture models
(Figure 6A). In contrast, anti-inflammatory cytokines IL-13
and IL-4 induced an increase in MRC1 immunoreactivity
in serum-exposed microglia at low concentrations (50 and
20 ng/ml, respectively; Figure 6A) but not in microglia
cultured in defined medium (Figure 6A). Higher concentrations
of anti-inflammatory cytokines IL-13 and IL-4 (100 and
50 ng/ml, respectively) were needed to observe an increase
in MRC1 immunoreactivity in microglia cultured in defined
medium (Figure 6A).
Microglia stimulation with anti or pro-inflammatory factors
is accompanied by metabolic reprogramming (Kelly and O’Neill,
2015). Thus, microglia treated with pro-inflammatory stimulus
would mainly rely on the glycolytic pathway to generate the
energy in the form of ATP. We assessed the energetic profiles of
microglia treated with anti- and pro-inflammatory factors in both
culture conditions using the Mito Stress Kit in a Seahorse XFe96
Analyzer (Agilent), in order to know if in both culture conditions
reprogramming is maintained.
Serum-exposed microglia treated with classical pro-
inflammatory stimuli (LPS and IFN-γ) showed a flat profile
regarding oxidative phosphorylation (OXPHOS), and all the
parameters (basal OCR, ATP production-associated OCR
and spare respiratory capacity) related to this molecular
process were practically abolished (Figures 6B,C). This suggest
a metabolism based mostly on the glycolytic process, in
order to rapidly obtain energy. Similarly, microglia cultured
in defined medium showed a significant reduction, but
not abolishment, in the same parameters of mitochondrial
respiration (Figures 6B,C). On the other hand, serum-exposed
microglia stimulated with anti-inflammatory factors showed a
significant increase in basal mitochondrial respiration and in
the spare capacity (Figures 6B,C). In contrast, mitochondrial
metabolism did not significantly change in microglia cultured
in defined medium after exposure to anti-inflammatory
factors. We further checked glycolysis in both culture
models. The ratio OCR/ECAR was significantly decreased
after exposure to pro-inflammatory factors in both culture
models (Figure 6D), thus indicating that microglia shift to a
glycolitic phenotype.
Finally, we used the fluorescent probe Bodipy to characterize
the lipid accumulation in lipid bodies (LBs) in both microglia
culture models. LBs, also referred to lipid droplets, are inducible
cytoplasmic organelles containing neutral lipids (triacylglycerol,
diacylglycerol or steryl esters) with roles in regulation of lipid
metabolism, cell signaling and activation, membrane trafficking
and control of the synthesis and secretion of inflammatory
mediators Pro-inflammatory stimuli such as LPS induce an
accumulation of LBs and an enhancement of their size in
microglia (Khatchadourian et al., 2012). Similar to other markers,
we observed a significant reduction in LBs in microglia cultured
in defined medium versus serum-exposed microglia (Figure 6E).
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FIGURE 2 | Microglial purinergic signaling was modified when cultured in the defined medium. (A–C) Immunostaining of the purinergic receptors P2Y12 (A), P2 × 7
(B) and P2 × 4 (C), all of them associated to microglial activation and function, in serum-exposed microglia and microglia cultured in defined medium. Scale
bars = 20 µm. Histograms represent the mean ± s.e.m of the P2 receptors fluorescence intensity per cell. (D) Immunostaining of the interferon regulatory factor 5
(IRF5), a transcription factor that controls immune response and the expression of P2 × 4, in serum-exposed microglia and microglia in defined medium. Scale
bars = 20 µm. Histograms show the quantification of the immunoreactivity and the ratio of IRF5 nuclear translocation in serum-exposed microglia and microglia
cultured in defined medium. Data shows mean ± s.e.m. of 20–30 cells per coverslip from 3–5 different experiments performed in duplicate. **p < 0.01,
***p < 0.001, Student’s t-test.
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FIGURE 3 | Microglial phagocytic capacity is reduced in microglia cultured in defined medium. (A) Phagocytosis of fluorescent microbeads (1 h) in microglia cultured
in defined medium and serum-exposed microglia. Scale bar = 20 µm. Histograms show the percentage of beads taken up by the cells (vs. total beads) and the
percentage of phagocytic cells. (B) Alexa-488-labeled myelin endocytosis at 1 h (top) and 24 h (bottom) in serum-exposed microglia and microglia in defined
medium. Scale bar = 20 µm. Histogram shows myelin endocytosis (1 h) and degradation (24 h) in both conditions. Notice that microglia cultured in defined medium
do not degrade myelin. Data shows mean ± s.e.m. of at least 50 cells in each experiment, n = 3 independent experiments performed in duplicate. *p < 0.05,
***p < 0.001, Student’s t-test.
DISCUSSION
Here we have characterized primary microglia isolated by
magnetic sorting and cultured in a chemically defined medium
with previously identified factors that promote microglial
survival (Bohlen et al., 2017). This condition is known to provoke
a ramified morphology that mirrors that acquired by these
cells in vivo in the normal adult brain. Besides, we identify
the obtained phenotype as a more representative example of
resting microglia observed in physiological conditions, ranging
from a downregulation of activation markers to a reduction of
different functionalities typically associated to the activated state
of microglia, including phagocytosis. Importantly, the capacity of
the cells to polarize to pro-inflammatory or anti-inflammatory
profiles when exposed to common agents, as well as the metabolic
reprogramming that cells suffer during this process remains
mainly unaltered.
Serum-free culture conditions are essential to reproduce
the physiological condition of the extracellular fluid of the
CNS, which is equal to the cerebrospinal fluid. Normal
cerebrospinal fluid (CSF) contains extremely low levels of
proteins and bioactive factors. In this study, we corroborated
that the chemically defined medium more closely reproduce
the in vivo extracellular medium than the medium containing
high percentage of serum and lead to a morphological and
functional microglia state resembling homeostatic microglia
in vivo. Moreover, the increased dynamics of microglia
cultured in defined medium also mimics the ones observed
in physiological conditions. Microglia functions are highly
regulated in vivo. Microglial activation is accompanied by
transcriptional reorganization of different signaling receptors,
in particular purinergic receptors. ATP is one of the most
important and ancient danger signal to alert and recruit immune
cells to the site of tissue damage following injury and to
orchestrate host immunity and inflammation. In this sense,
ATP is one of the main regulators of microglial functions.
Low ATP concentrations almost exclusively activate chemotaxis,
through P2Y12 receptor activation, in order to recruit cells
at the site of injury or inflammation (Haynes et al., 2006).
When the ATP concentration increases, additional effector
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FIGURE 4 | Microglial activation markers are reduced in defined medium. (A,B) Immunostaining of CD68 (A), a lysosomal marker related to activation and LC3 (B), a
marker of autophagy, in serum-exposed microglia and in microglia culture in defined medium. Data was obtained from at least 20 cells in each experiment, n = 3
independent experiments performed in duplicate. (C) Phagocytosis of fluorescent microbeads (24 h) in defined medium without and with exposure to LPS. Scale
bar = 20 µm. Histogram shows the percentage of phagocytic cells in both cases. Data was obtained from at least 50 cells in each experiment, n = 3 independent
experiments. Data shows mean ± s.e.m. *p < 0.05, **p < 0.01, Student’s t-test.
FIGURE 5 | Microglial surveillant capacity is increased when cultured in defined medium. Representative trajectories of single cells (left) are represented as
differentially colored lines. The point of intersection of the axes constitute the initial position of the cells. The histogram (right) represent the mean speed of their
movement. Both parameters were acquired using the Kinovea software. The time-lapse video (3 h, one frame per minute) was obtained using a Nikon Biostation
IM-Q microscope. Data shows mean ± s.e.m. from at least 20 cells/experiment, n = 3 independent experiments. *p < 0.05, Student’s t-test.
functions, such as phagocytosis and cytokine secretion, are also
triggered (Domercq et al., 2018). The switch on microglial
ATP responses are sometimes linked to an acute remodeling of
purinoceptor expression. Specifically, when microglia is activated
by pro-inflammatory factors or after pathological stimulus, they
upregulate P2 × 4 whereas P2Y12 receptors expression is
decreased (Koizumi et al., 2013; Domercq et al., 2018). Whereas
minor changes were observed in P2× 7 expression between both
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FIGURE 6 | Microglia activation and metabolic reprogramming in microglia cultured in defined medium. (A) Staining for iNOS (red) and mannose receptor (MRC1,
green) in differentially activated microglia (see methods) in serum-exposed microglia and in microglia cultured in defined medium. Notice that anti-inflammatory
factors were used at two concentration, low and high (see details in section “Methods”), in microglia cultured in defined medium whereas the low concentration of
stimulus was only efficient in serum-exposed microglia. Scale bar = 50 µm. Data shows mean ± s.e.m. of at least 20 cells/experiment, n = 3 independent
experiments. ***p < 0.001, ANOVA and Bonferroni post hoc analysis. (B) One representative experiment showing the metabolic profiles in microglia in defined
medium and serum-exposed microglia after incubation with pro-inflammatory or anti-inflammatory factors for 24 h. (C) Metabolic parameters related to
mitochondrial respiration in both microglia exposed to serum and microglia cultures in defined medium, after stimulation with pro-inflammatory or anti-inflammatory
factors for 24 h. Histograms represent the normalization of these parameters with respect to the control cells (mean + s.e.m.; n = 5–8 independent experiments).
*p < 0.05, **p < 0.01, ***p < 0.001, Student’s t-test. (D) OCR/ECAR ratio obtained from the basal levels of each parameter. Histogram represent mean + s.e.m. of
n = 5–8 independent experiments. For each experiment, 6 to 8 replicates were used. *p < 0.05, ***p < 0.001, ANOVA and Bonferroni post hoc analysis. (E) Lipid
accumulation in lipid bodies (LBs) represented by the expression of the fluorescent probe Bodipy, in serum-exposed microglia and microglia cultured in defined
medium. ***p < 0.001, Student’s t-test. Error bars in all the histograms represent standard error of the mean (s.e.m.).
microglia models, P2Y12 levels were higher and P2 × 4 was
dramatically downregulated in microglia cultured in the absence
of serum in the defined medium, probably as a result of IRF5
transcription factor downregulation. Importantly, this receptor is
quickly activated after injury in different pathological conditions,
defining the P2 × 4R+ reactive microglia (Masuda et al., 2014).
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These results suggest that microglia cultured in defined medium
have purinergic sensome characteristics of homeostatic microglia
in vivo (Hickman et al., 2013).
One of the functions of microglia is to phagocytose cellular
debris, myelin and pathogens. Microglia cultured in defined
medium showed lower phagocytic capacity of fluorescent beads
or myelin than microglia cultured in the presence of serum,
as previously described (Bohlen et al., 2017). Moreover, we
detected that myelin degradation at lysosomes is totally impaired
in microglia cultured in defined medium. Accordingly, the
number of CD68+ lysosomes or LC3 puncta is also severely
reduced in this model. It is well known that serum increases
microglia phagocytosis in vitro (Bohlen et al., 2017) as well
as in vivo. Indeed, lesions accomplished with blood brain
barrier alterations showed higher phagocytic activity in microglia
(Schilling et al., 2005; Greenhalgh and David, 2014). Thus, the
lower phagocytic activity of microglia in this optimized culture
conditions resembles homeostatic microglia in vivo. Although
this model could have some limitations to study phagocytosis
function in vitro, it could be used on the other hand to study
and identify factors and signaling pathways that potentiate
phagocytosis with possible therapeutic potential.
Immunometabolism is a fast growing field of immunology.
Macrophages and microglia undergo profound metabolic
reprogramming in response to environmental cues, such as
hypoxia, nutrient alterations, and in response to danger signals
and cytokines. In our study, cells cultured in defined medium also
decrease the OCR/ECAR ratio after exposure to proinflammatory
activators such as LPS and IFNγ, demonstrating that microglia
undergo a metabolic reprogramming under these conditions.
In contrast, microglia cultured in defined medium did not
show a clear increase in basal OXPHOS nor in the spare
respiratory capacity of the OXPHOS after exposure to anti-
inflammatory cytokines (IL-4 and IL-13). Altogether, data suggest
that stimulation with anti-inflammatory factors did not induce
any metabolic change in microglia cultured in defined medium.
These difference with regards to serum-exposed microglia may
suggest that microglia in defined medium are slightly shifted
toward an anti-inflammatory phenotype (Cherry et al., 2014).
Further metabolic characterization of MACS isolated microglia
and cultured in this conditions would shed light on the metabolic
signature of homeostatic microglia in vivo.
CONCLUSION
Magnetic-activated cell sorting isolated microglia and cultured
in a chemically defined medium without serum is a useful
but limited model to study microglia physiology. Receptor
expression is more representative of microglia in physiological
conditions and thus, its characterization would help to define
more accurately the signaling pathways that orchestrate microglia
function and activation. This model would also serve to study
metabolic reprogramming secondary to microglia stimulation
with pro-inflammatory factors; however, it is somehow limited
for phagocytic studies. In particular, the machinery to degrade
myelin seems to be impaired in microglia in this culture model.
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